Marvin Johnson is Director of MARINUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of MRNS, which is worth approximately $0. The most recent transaction as insider was on Feb 11, 2025, when has been sold 7,101 shares (Common Stock) at a price of $0.55 per share, resulting in proceeds of $3,905. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Marvin Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 11 2025
SELL
Sale (or disposition) back to the issuer
$3,905 $0.55 p/Share
7,101 Reduced 100.0%
0 Common Stock
Feb 07 2025
SELL
Sale (or disposition) back to the issuer
$2,963 $0.55 p/Share
5,389 Reduced 43.15%
7,101 Common Stock
Jan 21 2025
SELL
Open market or private sale
$869 $0.54 p/Share
1,610 Reduced 11.42%
12,490 Common Stock
Jun 18 2024
BUY
Grant, award, or other acquisition
-
2,300 Added 14.02%
14,100 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
4,600 Added 28.05%
11,800 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
7,200 Added 50.0%
7,200 Common Stock

Also insider at

TRVN
TREVENA INC Healthcare
MJ

Marvin Johnson

Director
Chesterbrook, PA

Track Institutional and Insider Activities on MRNS

Follow MARINUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNS shares.

Notify only if

Insider Trading

Get notified when an Marinus Pharmaceuticals, Inc. insider buys or sells MRNS shares.

Notify only if

News

Receive news related to MARINUS PHARMACEUTICALS, INC.

Track Activities on MRNS